Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001062993-26-001017·Advent Life Sciences LLP
Schedule 13G ownership disclosure
Aura Biosciences Inc
Common Stock, par value $0.00001 per share · CUSIP: 05153U107
Event date: 2026-02-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Advent Life Sciences LLP
Shares: 2,023,857 · Class: 3.258%
- Advent Life Sciences Fund I LP
Shares: 2,023,857 · Class: 3.258%
- Rajesh Parekh, Ph.D.
Shares: 2,071,857 · Class: 3.335%
- Advent Life Sciences Fund III LP
Shares: 2,023,857 · Class: 3.258%
- ALS III Carry and Co-Invest LP
Shares: 2,023,857 · Class: 3.258%
- Advent-Harrington Impact Fund LP
Shares: 2,023,857 · Class: 3.258%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001062993-26-001017
- Form type
- SCHEDULE 13G/A
- Filer
- Advent Life Sciences LLP
- CIK
- CIK 1601364
- Filed
- Feb 17, 2026
- Reporting period
- Feb 13, 2026
- Description
- Schedule 13G beneficial ownership